2025-2026

CHBRP generally analyzes introduced bills prior to their first Senate or Assembly Health Committee hearing. Completed CHBRP analyses (and the analyzed bill language) are available at http://chbrp.org/analysis/completed-analyses. As bills move through the Legislature, bills may be significantly amended, which may alter CHBRP’s projected impacts. The table, below, indicates the version of each analyzed bill and the extent to which CHBRP’s analyses remain relevant. Amended bill language and the bill status are available at http://leginfo.legislature.ca.gov/.

CHBRP’s analyses may still be of use after the legislative cycle concludes in order to inform future legislation, the implementation of analyzed legislation that is signed into law or included in California’s budget, and the ongoing evaluation of relevant health benefit mandates and repeals.

Bill Number Bill Author Bill Title Current location Bill amended since CHBRP analysis? Which portions of CHBRP’s analysis remain relevant?
AB 298 Bonta
Cost Sharing
 View status on https://leginfo.legislature.ca.gov/ No All portions of CHBRP's analysis remain relevant.
AB 350 Bonta
Fluoride treatment
 View status on https://leginfo.legislature.ca.gov/ Yes Bill amended – 7/07/2025 – Amended language would require coverage of fluoride varnish billed as a medical benefit without cost sharing. All portions of CHBRP's analysis remain relevant.
AB 432 Bauer-Kahan
Menopause
 View status on https://leginfo.legislature.ca.gov/ Yes Bill amended – 7/09/2025 – Amended language modifies the language regarding continuing medical education. All portions of CHBRP's analysis remain relevant.
AB 546 Caloza
HEPA purifiers and filters
 View status on https://leginfo.legislature.ca.gov/ Yes Bill amended – 7/07/2025 – Amended language would narrow the bill requirements to include coverage for only one HEPA purifier, under $500. The amendments also remove the prohibition on cost sharing, and limit eligibility for the benefit to only enrollees with health plans or policies in the large group market who are located in counties where a local or state emergency has been declared due to wildfires, and have a prescription for a HEPA purifier from their health care provider. The amended language would also require health plans/insurers to notify enrollees affected by a local or state emergency declaration due to wildfire of the benefit within 30 days of the declaration. The background and medical effectiveness sections of CHBRP’s analysis related to HEPA purifiers remain relevant. The amendments would increase administrative costs as a result of the notification mandate. Utilization of the benefit may decrease due to the requirement for a prescription, which would result in a corresponding decrease in fiscal impact.
AB 554 González
Antiretroviral drugs, drug devices, and drug products
 View status on https://leginfo.legislature.ca.gov/ Yes Bill amended – 6/24/2025 – Amended language narrows the mandate to require coverage without cost sharing for only preexposure prophylaxis under grandfathered and nongrandfathered plans. Because coverage for preexposure prophylaxis is already required under the California and Federal Preventive Service Acts, the bill would only impact grandfathered plans. The amendments would result in a decrease in the projected fiscal impact from CHBRP’s analysis. In addition, amended language defines a long-acting drug, drug device, or drug product as not therapeutically equivalent to a long-acting drug, drug device, or drug product with a different duration. Although there are currently a limited number of antiretroviral drugs formulated with the same ingredients but with different durations, there are extended duration formulations of antiretroviral drugs in development. In the long-term, if these developments are successful, the amended language would prohibit these extended duration formulations from being subject to prior authorization and step therapy and would increase the fiscal impact of the bill. All other portions of CHBRP’s analysis remain relevant.
AB 575 Arambula
Obesity Prevention Treatment Parity Act
 View status on https://leginfo.legislature.ca.gov/ No All portions of CHBRP's analysis remain relevant.
AB 1032 Harabedian and Rivas
Coverage for behavioral health visits
 View status on https://leginfo.legislature.ca.gov/ Yes Bill amended – 5/05/2025 – Along with other technical changes, the amended language specifies that coverage applies only to large group plans (removes individual and small group plans) and adds coverage for members in the California State Teachers’ Retirement System (CalSTRS) who receive a health care benefit under CalSTRS. These changes may impact estimated costs but the magnitude of such changes is unknown. All other portions of CHBRP’s analysis remain relevant.
SB 40 Wiener
Insulin
 View status on https://leginfo.legislature.ca.gov/ Yes Bill amended – 6/27/2025 – The amendments would result in minimal differences compared with CHBRP's estimate of SB 40 as introduced. Estimated expenditure impacts in the small group and individual markets would be delayed by one year and differences would exist based on the number of enrollees in these markets in 2027 as compared with the estimated population in 2026. Additionally, the amendment that limits the cost sharing cap to insulins placed on Tier 1 and Tier 2 could result in some enrollees experiencing cost sharing above the $35 copay cap and therefore would decrease the estimated fiscal estimates included in CHBRP’s analysis. However, it is likely the requirements pertaining to which insulins must be covered on Tier 1 and Tier 2 would capture a large majority of the insulins enrollees use. All other portions of CHBRP’s analysis remain relevant.
SB 242 Blakespear
Medicare supplement coverage: open enrollment periods
 View status on https://leginfo.legislature.ca.gov/ Yes Bill amended – 5/05/2025 – The bill amendment moves away from “attained age" to "age at issue" (which is another popular way to set premiums in this market). CHBRP anticipates the amended language would result in a smaller but still significant premium increase because there would be a barrier to enrollment in Medicare Supplement plans for older beneficiaries - it would not be as worthwhile for beneficiaries to wait until they are older. However, the guaranteed issue provision remaining in SB 242 would still cause some people to choose to wait to purchase Medicare Supplement plans. The amended language would likely reduce adverse selection, which in turn should reduce the magnitude of premium increases and thus increase enrollment of lower risk, less costly individuals.
SB 257 Wahab
PARENT Act
 View status on https://leginfo.legislature.ca.gov/ Yes Bill amended – 7/03/2025 – Amended language removes three clauses restricting health care service plans and policies’ mechanisms for limiting coverage for gestational carriers (increasing premiums or cost sharing, penalizing the reimbursement of an attending health care provider, and reducing coverage). Broad language prohibiting health care service plans and policies from “otherwise discriminat[ing] against an enrollee, an enrollee’s newborn, or an attending health care provider” remains. All portions of CHBRP’s analysis remain relevant.
SB 535 Richardson
Obesity Treatment Parity Act
 View status on https://leginfo.legislature.ca.gov/ No All portions of CHBRP's analysis remain relevant.
SB 626 Smallwood-Cuevas
Perinatal health screenings and treatment
 View status on https://leginfo.legislature.ca.gov/ Yes Bill amended – 5/05/2025 – Amended language would encourage but no longer require health plans and policies to improve screening and treatment for perinatal mental health conditions through the use of medications and digital therapeutics approved by the FDA for perinatal mental health conditions. Amended language would also allow providers to adhere to guidelines or standards adopted by other recognized professional bodies if adherence to ACOG clinical guidelines does not align with a provider’s scope of practice. The background and medical effectiveness sections of CHBRP’s analysis remain relevant.
Bill Number Bill Author Bill Title Current location Amended Which portions of CHBRP’s analysis remain relevant?